$BSVN
Bank7 Corp.

2022 Q4 Form 10-Q Financial Statement

#000114036122041387 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $21.69M $14.01M
YoY Change 54.85% 8.37%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $343.0K $351.0K $260.0K
YoY Change 37.2% 35.0% -7.14%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $2.646M $729.0K
YoY Change 262.96% -44.98%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $11.36M $10.40M $8.327M
YoY Change 47.75% 24.94% 36.49%
Income Tax $2.973M $2.363M $2.063M
% Of Pretax Income 26.17% 22.71% 24.77%
Net Earnings $8.386M $8.041M $6.264M
YoY Change 47.49% 28.37% 41.08%
Net Earnings / Revenue 37.07% 44.72%
Basic Earnings Per Share $0.88 $0.69
Diluted Earnings Per Share $908.3K $873.2K $0.69
COMMON SHARES
Basic Shares Outstanding 9.116M 9.100M 9.053M
Diluted Shares Outstanding 9.210M 9.105M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $109.1M $147.2M $205.8M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $13.11M $13.35M $8.800M
YoY Change -24.05% 51.73% -6.25%
Goodwill $8.600M $8.100M $1.000M
YoY Change 1.43% 710.0% 0.0%
Intangibles $1.300M $1.412M
YoY Change -20.88%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.584B $1.581B $1.146B
YoY Change 17.3% 37.93% 17.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.715M $7.351M $5.400M
YoY Change 70.44% 36.13% 38.46%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.77M $7.797M $5.400M
YoY Change 88.93% 44.39% 20.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $10.77M $7.797M $5.400M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.440B $1.445B $1.024B
YoY Change 17.74% 41.15% 17.93%
SHAREHOLDERS EQUITY
Retained Earnings $58.05M $51.12M
YoY Change 75.12%
Common Stock $95.35M $95.15M
YoY Change 1.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $144.1M $135.8M $122.4M
YoY Change
Total Liabilities & Shareholders Equity $1.584B $1.581B $1.146B
YoY Change 17.3% 37.93% 17.76%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income $8.386M $8.041M $6.264M
YoY Change 47.49% 28.37% 41.08%
Depreciation, Depletion And Amortization $343.0K $351.0K $260.0K
YoY Change 37.2% 35.0% -7.14%
Cash From Operating Activities $9.779M $5.018M $5.510M
YoY Change 36.96% -8.93% 94.01%
INVESTING ACTIVITIES
Capital Expenditures $21.00K -$45.00K -$80.00K
YoY Change -106.0% -43.75% -11.11%
Acquisitions
YoY Change
Other Investing Activities -$38.64M -$71.09M $3.770M
YoY Change -202.52% -1985.68% -109.86%
Cash From Investing Activities -$38.66M -$71.14M $3.690M
YoY Change -203.54% -2027.78% -109.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -9.243M 89.92M 8.820M
YoY Change -79.63% 919.51% -127.92%
NET CHANGE
Cash From Operating Activities 9.779M 5.018M 5.510M
Cash From Investing Activities -38.66M -71.14M 3.690M
Cash From Financing Activities -9.243M 89.92M 8.820M
Net Change In Cash -38.13M 23.80M 18.02M
YoY Change 4136.22% 32.1% -126.87%
FREE CASH FLOW
Cash From Operating Activities $9.779M $5.018M $5.510M
Capital Expenditures $21.00K -$45.00K -$80.00K
Free Cash Flow $9.758M $5.063M $5.590M
YoY Change 30.28% -9.43% 90.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.36
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.33
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
135819000
CY2022Q3 bsvn Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Loans Acquired
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoansAcquired
68800000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Central Index Key
EntityCentralIndexKey
0001746129
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38656
dei Entity Registrant Name
EntityRegistrantName
Bank7 Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
OK
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-0763496
dei Entity Address Address Line1
EntityAddressAddressLine1
1039 N.W. 63rd Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Oklahoma City
dei Entity Address State Or Province
EntityAddressStateOrProvince
OK
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
73116-7361
dei City Area Code
CityAreaCode
405
dei Local Phone Number
LocalPhoneNumber
810-8600
dei Security12b Title
Security12bTitle
Common Stock, $0.01 Par Value Per Share
dei Trading Symbol
TradingSymbol
BSVN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9115739
CY2022Q3 us-gaap Federal Funds Sold
FederalFundsSold
0
CY2021Q4 us-gaap Federal Funds Sold
FederalFundsSold
9493000
CY2022Q3 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
204000
CY2021Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
464000
CY2022Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
2348000
CY2021Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
750000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
2843000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
3325000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-3200000
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.11
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
122409000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
135819000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
122409000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
24000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
11000
bsvn Payments For Net Cash Settlement Of Equity Compensation
PaymentsForNetCashSettlementOfEquityCompensation
29000
bsvn Payments For Net Cash Settlement Of Equity Compensation
PaymentsForNetCashSettlementOfEquityCompensation
181000
us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
0
us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
1000
CY2022Q3 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-649000
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-411000
CY2022Q3 bsvn Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Gross Loans Acquired
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGrossLoansAcquired
69700000
CY2022Q3 bsvn Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Loan Discount
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanDiscount
818000
CY2022Q3 bsvn Reserve Funds To Be Maintained With Federal Reserve Bank
ReserveFundsToBeMaintainedWithFederalReserveBank
0
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
8041000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
6264000
us-gaap Net Income Loss
NetIncomeLoss
21249000
us-gaap Net Income Loss
NetIncomeLoss
17473000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9100789
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9052718
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9095724
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9051112
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
108965
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
52537
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
99204
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
27559
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9209754
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9105255
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9194928
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.34
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9078671
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.93
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.87
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.92
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
0
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
10000
CY2022Q3 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0
CY2022Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
1236578000
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1030978000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
13153000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10316000
CY2022Q3 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
3427000
CY2021Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
2577000
CY2022Q3 us-gaap Notes Receivable Net
NotesReceivableNet
1219998000
CY2021Q4 us-gaap Notes Receivable Net
NotesReceivableNet
1018085000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10819000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
19000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
5000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery
14000
CY2022Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
2348000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
13153000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
12306000
CY2021Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
3752000
CY2021Q3 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
2000
CY2021Q3 us-gaap Financing Receivable Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery
3750000
CY2021Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
750000
CY2021Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
9306000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10316000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
20000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
14000
us-gaap Financing Receivable Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery
6000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
2843000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
13153000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
9639000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
3813000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
155000
us-gaap Financing Receivable Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery
3658000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
3325000
CY2021Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
9306000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
139000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
13014000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
13153000
CY2022Q3 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
27001000
CY2022Q3 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1209577000
CY2022Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
1236578000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
253000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
10063000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10316000
CY2021Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
23854000
CY2021Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1007124000
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1030978000
CY2022Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
1236578000
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1030978000
CY2022Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
1236578000
CY2022Q3 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
9946000
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1030978000
CY2021Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
496000
CY2022Q3 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
27642000
CY2022Q3 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
26862000
CY2022Q3 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
139000
CY2022Q3 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
27001000
CY2022Q3 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
139000
CY2022Q3 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
22824000
CY2022Q3 bsvn Impaired Financing Receivable Interest Income Expense Accrual Method
ImpairedFinancingReceivableInterestIncomeExpenseAccrualMethod
838000
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
23767000
bsvn Impaired Financing Receivable Interest Income Expense Accrual Method
ImpairedFinancingReceivableInterestIncomeExpenseAccrualMethod
1207000
CY2021Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
24906000
CY2021Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
23601000
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
253000
CY2021Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
23854000
CY2021Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
253000
CY2021Q3 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
27031000
CY2021Q3 bsvn Impaired Financing Receivable Interest Income Expense Accrual Method
ImpairedFinancingReceivableInterestIncomeExpenseAccrualMethod
292000
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
24904000
bsvn Impaired Financing Receivable Interest Income Expense Accrual Method
ImpairedFinancingReceivableInterestIncomeExpenseAccrualMethod
1115000
us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
0
CY2022Q3 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
8218000
CY2022Q3 bsvn Financing Receivable Recorded Investment Troubled Debt Restructurings
FinancingReceivableRecordedInvestmentTroubledDebtRestructurings
0
CY2022Q3 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
9946000
CY2022Q3 bsvn Financing Receivable Recorded Investment Non Performing Loans
FinancingReceivableRecordedInvestmentNonPerformingLoans
18164000
CY2021Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
9885000
CY2021Q4 bsvn Financing Receivable Recorded Investment Troubled Debt Restructurings
FinancingReceivableRecordedInvestmentTroubledDebtRestructurings
0
CY2021Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
496000
CY2021Q4 bsvn Financing Receivable Recorded Investment Non Performing Loans
FinancingReceivableRecordedInvestmentNonPerformingLoans
10381000
CY2022Q3 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
1300000
CY2021Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
1400000
CY2022Q3 us-gaap Statutory Accounting Practices Statutory Amount Available For Dividend Payments Without Regulatory Approval
StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval
54300000
CY2022Q3 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
0
CY2021Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
0
us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.05
CY2022Q3 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
74000
CY2021Q3 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
63000
us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
281000
us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
204000
CY2022Q3 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
230672000
CY2021Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
206202000
CY2022Q3 us-gaap Goodwill
Goodwill
8100000

Files In Submission

Name View Source Status
0001140361-22-041387-index-headers.html Edgar Link pending
0001140361-22-041387-index.html Edgar Link pending
0001140361-22-041387.txt Edgar Link pending
0001140361-22-041387-xbrl.zip Edgar Link pending
brhc10043986_10q.htm Edgar Link pending
brhc10043986_ex31-1.htm Edgar Link pending
brhc10043986_ex31-2.htm Edgar Link pending
brhc10043986_ex32-1.htm Edgar Link pending
bsvn-20220930.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
brhc10043986_10q_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bsvn-20220930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bsvn-20220930_cal.xml Edgar Link unprocessable
bsvn-20220930_lab.xml Edgar Link unprocessable
bsvn-20220930_pre.xml Edgar Link unprocessable